Anebulo Pharmaceuticals (FRA:214) Total Stockholders Equity : €4.59 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Anebulo Pharmaceuticals Total Stockholders Equity?

Anebulo Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €4.59 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Anebulo Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 was €0.18. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Anebulo Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Anebulo Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Anebulo Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anebulo Pharmaceuticals Total Stockholders Equity Chart

Anebulo Pharmaceuticals Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

-0.15

17.77

14.25

9.79

Anebulo Pharmaceuticals Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial										12.09	9.79	7.81	5.95	4.59

Anebulo Pharmaceuticals (FRA:214) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Anebulo Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4.586	-	0)	/	25.9332
	=	0.18

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Anebulo Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	4.586
	=	0.00

Anebulo Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Anebulo Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Anebulo Pharmaceuticals (FRA:214) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anebulo Pharmaceuticals Inc (FRA:214) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ANEB:USA

Address

1017 Ranch Road 620 South, Suite 107, Lakeway, TX, USA, 78734

Website

https://www.anebulo.com

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Anebulo Pharmaceuticals (FRA:214) Headlines

No Headlines